PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 169 filers reported holding PTC THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,425,255 | -58.5% | 108,222 | -24.7% | 0.00% | -60.0% |
| Q2 2023 | $5,848,468 | -9.6% | 143,803 | +7.7% | 0.01% | -16.7% |
| Q1 2023 | $6,466,159 | +6.9% | 133,488 | -15.8% | 0.01% | +20.0% |
| Q4 2022 | $6,048,762 | -19.7% | 158,469 | +5.6% | 0.01% | -28.6% |
| Q3 2022 | $7,531,000 | +33.6% | 150,026 | +6.7% | 0.01% | +40.0% |
| Q2 2022 | $5,635,000 | +7.4% | 140,654 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $5,248,000 | -6.3% | 140,654 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $5,602,000 | +7.0% | 140,654 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $5,234,000 | -8.6% | 140,654 | +3.8% | 0.00% | 0.0% |
| Q2 2021 | $5,728,000 | -13.1% | 135,506 | -2.6% | 0.00% | -20.0% |
| Q1 2021 | $6,588,000 | -27.2% | 139,134 | -6.1% | 0.01% | -28.6% |
| Q4 2020 | $9,045,000 | +36.8% | 148,210 | +4.8% | 0.01% | +16.7% |
| Q3 2020 | $6,612,000 | -5.1% | 141,429 | +3.0% | 0.01% | -14.3% |
| Q2 2020 | $6,964,000 | +16.1% | 137,249 | +2.1% | 0.01% | 0.0% |
| Q1 2020 | $5,999,000 | -29.6% | 134,485 | -24.2% | 0.01% | -12.5% |
| Q4 2019 | $8,525,000 | +103.8% | 177,499 | +43.5% | 0.01% | +100.0% |
| Q3 2019 | $4,184,000 | +6.0% | 123,709 | +41.1% | 0.00% | -20.0% |
| Q2 2019 | $3,947,000 | +23.6% | 87,702 | +3.4% | 0.01% | +25.0% |
| Q1 2019 | $3,193,000 | +0.8% | 84,839 | -8.1% | 0.00% | 0.0% |
| Q4 2018 | $3,168,000 | -31.3% | 92,302 | -5.9% | 0.00% | -33.3% |
| Q3 2018 | $4,612,000 | +175.7% | 98,131 | +97.9% | 0.01% | +200.0% |
| Q2 2018 | $1,673,000 | +57.2% | 49,592 | +26.2% | 0.00% | 0.0% |
| Q1 2018 | $1,064,000 | +227.4% | 39,309 | +101.6% | 0.00% | – |
| Q4 2017 | $325,000 | -53.4% | 19,500 | -44.1% | 0.00% | -100.0% |
| Q3 2017 | $698,000 | +95.5% | 34,878 | +78.9% | 0.00% | 0.0% |
| Q2 2017 | $357,000 | +85.9% | 19,500 | 0.0% | 0.00% | – |
| Q1 2017 | $192,000 | -13.9% | 19,500 | -4.4% | 0.00% | – |
| Q4 2016 | $223,000 | -22.0% | 20,400 | 0.0% | 0.00% | – |
| Q3 2016 | $286,000 | +85.7% | 20,400 | -7.3% | 0.00% | – |
| Q2 2016 | $154,000 | +5.5% | 22,000 | -3.1% | 0.00% | – |
| Q1 2016 | $146,000 | -81.4% | 22,700 | -6.2% | 0.00% | -100.0% |
| Q4 2015 | $784,000 | +21.4% | 24,200 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $646,000 | -44.5% | 24,200 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $1,165,000 | -34.6% | 24,200 | -25.3% | 0.00% | 0.0% |
| Q1 2015 | $1,781,000 | 0.0% | 32,403 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,781,000 | +286.3% | 32,403 | +209.5% | 0.00% | +100.0% |
| Q3 2014 | $461,000 | – | 10,468 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,235,196 | $162,140,742 | 3.42% |
| Camber Capital Management LP | 3,400,000 | $76,194 | 2.51% |
| ARMISTICE CAPITAL, LLC | 6,150,000 | $137,821,500 | 2.11% |
| GREAT POINT PARTNERS LLC | 500,000 | $11,205,000 | 2.04% |
| COWEN AND COMPANY, LLC | 799,511 | $17,917,041 | 1.25% |
| GEORGE KAISER FAMILY FOUNDATION | 45,816 | $6,491,211 | 1.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 218,459 | $4,895,666 | 0.89% |
| SECTORAL ASSET MANAGEMENT INC | 187,016 | $4,191,029 | 0.82% |
| Nebula Research & Development LLC | 21,858 | $489,838 | 0.26% |
| Phocas Financial Corp. | 64,701 | $1,450,000 | 0.21% |